This book examines the critical role of safety pharmacology in ensuring drug safety throughout the pharmaceutical lifecycle. It details the regulatory requirements for safety pharmacology studies during drug development and explores their application in post-marketing surveillance, providing a comprehensive overview for researchers and regulatory professionals.

This text is recognized as a thorough resource for understanding the regulatory landscape and scientific methodologies of safety pharmacology. It is structured to guide professionals through the complexities of drug approval processes and ongoing safety monitoring. The book's focus on both preclinical and post-marketing aspects makes it a valuable reference for those involved in pharmaceutical development and regulatory affairs.